Clinical Trial Update: Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating rFVIIIFc for immune tolerance induction in hemophilia A patients with inhibitors who previously failed ITI therapies has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rFVIIIFc (recombinant factor VIII Fc fusion protein)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2021-11-30